Skip to main content
SpringerLink
Log in

Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose–response meta-analysis

  • Original paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Background

Mounting experimental evidence supports a protective effect of high 25-hydroxyvitamin D (25[OH]D), a good indicator of vitamin D status, on risk of various cancers including lung cancer. However, prospective observational studies examining the 25(OH)D–lung cancer association reported inconsistent findings. A dose–response meta-analysis was carried out to elucidate the subject.

Methods

Potentially eligible studies were identified by searching PubMed and EMBASE databases, and by carefully reviewing the bibliographies of retrieved publications. The summary relative risks (RRs) with 95 % confidence intervals (CIs) were calculated using the random-effects model.

Results

Thirteen reports from ten prospective studies were included, totaling 2,227 lung cancer events. Results of the meta-analysis showed a significant 5 % (RR 0.95, 95 % CI 0.91–0.99) reduction in the risk of lung cancer for each 10 nmol/L increment in 25(OH)D concentrations. This inverse association was not significantly modified by area, study duration, sex, methods for 25(OH)D measurement, baseline 25(OH)D levels, or quality score of included studies. There was evidence of a nonlinear relationship between 25(OH)D and risk of lung cancer (p-nonlinearity = 0.02), with the greatest reductions in risk observed at 25(OH)D of nearly 53 nmol/L, and remained protective until approximately 90 nmol/L. Further increases showed no significant association with cancer risk, but scanty data were included in the analyses of high-level 25(OH)D. There was no evidence of publication bias.

Conclusion

This dose–response meta-analysis of prospective studies suggests that 25(OH)D may be associated with reduced risk of lung cancer, in particular among subjects with vitamin D deficiencies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. World Health Organization. GLOBOCAN (2012) Estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx

  2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  3. Ezzati M, Lopez AD (2003) Estimates of global mortality attributable to smoking in 2000. Lancet 362:847–852

    Article  PubMed  Google Scholar 

  4. Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, Gapstur S, Patel AV, Andrews K, Gansler T (2012) American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 62:30–67

    Article  PubMed  Google Scholar 

  5. Zerwekh JE (2008) Blood biomarkers of vitamin D status. Am J Clin Nutr 87:1087S–1091S

    CAS  PubMed  Google Scholar 

  6. van der Rhee H, Coebergh JW, de Vries E (2009) Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies. Eur J Cancer Prev 18:458–475

    Article  PubMed  Google Scholar 

  7. Higashimoto Y, Ohata M, Nishio K, Iwamoto Y, Fujimoto H, Uetani K, Suruda T, Nakamura Y, Funasako M, Saijo N (1996) 1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line. Anticancer Res 16:2653–2659

    CAS  PubMed  Google Scholar 

  8. Nakagawa K, Sasaki Y, Kato S, Kubodera N, Okano T (2005) 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis 26:1044–1054

    Article  CAS  PubMed  Google Scholar 

  9. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS (1999) 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res 59:2644–2649

    CAS  PubMed  Google Scholar 

  10. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P (2011) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128:1414–1424

    Article  CAS  PubMed  Google Scholar 

  11. Zhang L, Wang S, Che X, Li X (2015) Vitamin D and lung cancer risk: a comprehensive review and meta-analysis. Cell Physiol Biochem 36:299–305

    Article  PubMed  Google Scholar 

  12. Cheng TY, Neuhouser ML (2012) Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient–nutrient interaction. Cancer Causes Control 23:1557–1565

    Article  PubMed  Google Scholar 

  13. Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI (2010) Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988–2006). Cancer Res 70:8587–8597

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Afzal S, Bojesen SE, Nordestgaard BG (2013) Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. Clin Chem 59:771–780

    Article  CAS  PubMed  Google Scholar 

  15. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008–2012

    Article  CAS  PubMed  Google Scholar 

  16. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2013) The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. www.ohri.ca/programs/clinical_epidemiology/oxford.htm

  17. Weinstein SJ, Yu K, Horst RL, Parisi D, Virtamo J, Albanes D (2011) Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case–control study. PLoS One 6:e20796

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  CAS  PubMed  Google Scholar 

  19. Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose–response data, with applications to meta-analysis. Am J Epidemiol 135:1301–1309

    CAS  PubMed  Google Scholar 

  20. Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized dose–respose data. Stata J 6:40–57

    Google Scholar 

  21. Ordonez-Mena JM, Schottker B, Fedirko V, Jenab M, Olsen A, Halkjaer J, Kampman E, de Groot L, Jansen E, Bueno-de-Mesquita HB, Peeters PH, Siganos G, Wilsgaard T, Perna L, Holleczek B, Pettersson-Kymmer U, Orfanos P, Trichopoulou A, Boffetta P, Brenner H (2015) Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium. Eur J Epidemiol. doi:10.1007/s10654-015-0040-7

  22. Wong YY, Hyde Z, McCaul KA, Yeap BB, Golledge J, Hankey GJ, Flicker L (2014) In older men, lower plasma 25-hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancer. PLoS One 9:e99954

    Article  PubMed Central  PubMed  Google Scholar 

  23. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D (2012) Meta-analysis for linear and nonlinear dose–response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175:66–73

    Article  PubMed Central  PubMed  Google Scholar 

  24. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558

    Article  PubMed  Google Scholar 

  25. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Freedman DM, Looker AC, Chang SC, Graubard BI (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99:1594–1602

    Article  CAS  PubMed  Google Scholar 

  27. Ordonez-Mena JM, Schottker B, Haug U, Muller H, Kohrle J, Schomburg L, Holleczek B, Brenner H (2013) Serum 25-hydroxyvitamin d and cancer risk in older adults: results from a large German prospective cohort study. Cancer Epidemiol Biomark Prev 22:905–916

    Article  CAS  Google Scholar 

  28. Ananthakrishnan AN, Cheng SC, Cai T, Cagan A, Gainer VS, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP (2014) Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 12:821–827

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC (2006) Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451–459

    Article  CAS  PubMed  Google Scholar 

  30. Kilkkinen A, Knekt P, Heliovaara M, Rissanen H, Marniemi J, Hakulinen T, Aromaa A (2008) Vitamin D status and the risk of lung cancer: a cohort study in Finland. Cancer Epidemiol Biomark Prev 17:3274–3278

    Article  CAS  Google Scholar 

  31. Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Jorgensen T, Roswall N, Larsen SC, Linneberg A (2014) Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer. Cancer Epidemiol Biomark Prev 23:1220–1229

    Article  CAS  Google Scholar 

  32. Chien KL, Hsu HC, Chen PC, Lin HJ, Su TC, Chen MF, Lee YT (2015) Total 25-hydroxyvitamin D concentration as a predictor for all-cause death and cardiovascular event risk among ethnic Chinese adults: a cohort study in a Taiwan community. PLoS One 10:e0123097

    Article  PubMed Central  PubMed  Google Scholar 

  33. Durup D, Jorgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B (2012) A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metab 97:2644–2652

    Article  CAS  PubMed  Google Scholar 

  34. Ford ES, Zhao G, Tsai J, Li C (2011) Vitamin D and all-cause mortality among adults in USA: findings from the National Health and Nutrition Examination Survey Linked Mortality Study. Int J Epidemiol 40:998–1005

    Article  PubMed  Google Scholar 

  35. Grant WB (2010) Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B 101:130–136

    Article  CAS  PubMed  Google Scholar 

  36. Kristal AR, Till C, Song X, Tangen CM, Goodman PJ, Neuhauser ML, Schenk JM, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Klein EA (2014) Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial. Cancer Epidemiol Biomark Prev 23:1494–1504

    Article  CAS  Google Scholar 

  37. Brandenburg VM, Vervloet MG, Marx N (2012) The role of vitamin D in cardiovascular disease: from present evidence to future perspectives. Atherosclerosis 225:253–263

    Article  CAS  PubMed  Google Scholar 

  38. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW (2008) Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 181:7090–7099

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Ordonez-Moran P, Larriba MJ, Pendas-Franco N, Aguilera O, Gonzalez-Sancho JM, Munoz A (2005) Vitamin D and cancer: an update of in vitro and in vivo data. Front Biosci 10:2723–2749

    Article  CAS  PubMed  Google Scholar 

  41. Afzal S, Bojesen SE, Nordestgaard BG (2013) Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and meta-analysis. Clin Chem 59:381–391

    Article  CAS  PubMed  Google Scholar 

  42. Lee JY, Jeon I, Lee JM, Yoon JM, Park SM (2013) Diabetes mellitus as an independent risk factor for lung cancer: a meta-analysis of observational studies. Eur J Cancer 49:2411–2423

    Article  PubMed  Google Scholar 

  43. Cheng TY, Goodman GE, Thornquist MD, Barnett MJ, Beresford SA, LaCroix AZ, Zheng Y, Neuhouser ML (2014) Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers. Int J Cancer 135:2135–2145

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  44. Cheng TY, Lacroix AZ, Beresford SA, Goodman GE, Thornquist MD, Zheng Y, Chlebowski RT, Ho GY, Neuhouser ML (2013) Vitamin D intake and lung cancer risk in the Women’s Health Initiative. Am J Clin Nutr 98:1002–1011

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Redaniel MT, Gardner MP, Martin RM, Jeffreys M (2014) The association of vitamin D supplementation with the risk of cancer in postmenopausal women. Cancer Causes Control 25:267–271

    Article  PubMed  Google Scholar 

  46. Takata Y, Shu XO, Yang G, Li H, Dai Q, Gao J, Cai Q, Gao YT, Zheng W (2013) Calcium intake and lung cancer risk among female nonsmokers: a report from the Shanghai Women’s Health Study. Cancer Epidemiol Biomark Prev 22:50–57

    Article  CAS  Google Scholar 

  47. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77:204–210

    CAS  PubMed  Google Scholar 

  48. Lazzeroni M, Serrano D, Pilz S, Gandini S (2013) Vitamin D supplementation and cancer: review of randomized controlled trials. Anticancer Agents Med Chem 13:118–125

    Article  CAS  PubMed  Google Scholar 

  49. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA (2011) Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 155:827–838

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nutrition and Food Hygiene, School of Public Health, Soochow University, 199 Renai Road, Suzhou, 215123, China

    Guo-Chong Chen, Zhongxiao Wan & Li-Qiang Qin

  2. Department of Labor Hygiene and Environmental Health, School of Public Health, Soochow University, Suzhou, China

    Zeng-Li Zhang

  3. Special Procurement Ward, The First Affiliated Hospital of Soochow University, Suzhou, China

    Ling Wang

  4. DSM Nutritional Products Ltd., Human Nutrition and Health, Kaiseraugst, Switzerland

    Peter Weber & Manfred Eggersdorfer

  5. DSM Nutritional Products Ltd., Human Nutrition and Health, No. 9 Dongdaqiao Road, Beijing, 100020, China

    Weiguo Zhang

Authors
  1. Guo-Chong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zeng-Li Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhongxiao Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ling Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peter Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Manfred Eggersdorfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Li-Qiang Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Weiguo Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Li-Qiang Qin or Weiguo Zhang.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 30 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, GC., Zhang, ZL., Wan, Z. et al. Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose–response meta-analysis. Cancer Causes Control 26, 1719–1728 (2015). https://doi.org/10.1007/s10552-015-0665-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-015-0665-6

Keywords

Search

Navigation